Tag: Health Care
Displaying 101 - 120 of 1394 results.
Pages
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Danaher Corporation’s acquisition of GE Biopharma would likely reduce competition in highly concentrated markets that supply biopharmaceutical companies with key inputs.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Össur Hf’s proposed acquisition of College Park Industries, Inc. would violate federal antitrust law.
La Comisión Federal de Comercio (FTC, por su sigla en inglés) ha emitido una alerta para que los consumidores se mantengan vigilantes a los asilos de ancianos y residencias de vida asistida que les están exigiendo a sus residentes con Medicaid que firmen sus cheques de estímulo para endosarlos a...
The Federal Trade Commission has issued an alert to consumers to be on the lookout for nursing homes and assisted living facilities that are requiring residents who are on Medicaid to sign their stimulus checks over to the facilities.
Pharmaceutical companies AbbVie Inc. and Allergan plc have agreed to divest assests to settle Federal Trade Commission charges that AbbVie's proposed $63 billion acquisition of Allergan would violate federal antitrust law. On Sept. 4, 2020, the Commission announced the final consent...
Federal Trade Commission Chairman Joe Simons released a summary of the agency’s 2019 Annual Highlights today, calling attention to the Commission’s ongoing efforts to protect consumers and promote a competitive marketplace.
The Federal Trade Commission has filed an amended complaint in federal court against Vyera Pharmaceuticals, LLC, adding six new states as co-complainants.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Compassion First’s proposed $5 billion acquisition of National Veterinary Associates, or NVA, would violate federal antitrust law.
Össur Hf and College Park Industries, Inc., both makers of prosthetic limbs, have agreed to divest College Park’s myoelectric elbow business to settle Federal Trade Commission charges that Össur’s proposed acquisition of College Park would violate federal antitrust law.
Össur Hf and College Park Industries, Inc., both makers of prosthetic limbs, have agreed to divest College Park’s myoelectric elbow business to settle Federal Trade Commission charges that Össur’s proposed acquisition of College Park would violate federal antitrust law.
